HIF-1 regulation: not so easy come, easy go

Trends in Biochemical Sciences

Volumn 33, Issue 11, 2008, Pages 526-534

  Koh, Mei Yee ^a   Spivak Kroizman, Taly R ^a   Powis, Garth ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; VON HIPPEL LINDAU PROTEIN;

ANAEROBIC METABOLISM; ANGIOGENESIS; HUMAN; HYPOXIA; MOLECULAR MECHANICS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SUMOYLATION;

ANIMALS; ANOXIA; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROTEIN BIOSYNTHESIS; RECEPTORS, CELL SURFACE; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; UBIQUITIN THIOLESTERASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 54249164450     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2008.08.002     Document Type: Review

References (85)

1. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93 (2001) 266-276
2. Pouyssegur J., et al. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
3. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12 (1992) 5447-5454
4. Semenza G.L. Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell 5 (2004) 405-406
5. Welsh S.J., et al. The hypoxic inducible stress response as a target for cancer drug discovery. Semin. Oncol. 33 (2006) 486-497
6. 2 tension. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5510-5514
7. Wiesener M.S., et al. Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J. 17 (2003) 271-273
8. Gu Y.Z., et al. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene Expr. 7 (1998) 205-213
9. Makino Y., et al. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus. J. Biol. Chem. 277 (2002) 32405-32408
10. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
11. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
12. Hagen T., et al. Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 302 (2003) 1975-1978
13. Simon M.C. Mitochondrial reactive oxygen species are required for hypoxic HIFα stabilization. Adv. Exp. Med. Biol. 588 (2006) 165-170
14. Lin X., et al. A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 174-179
15. Berchner-Pfannschmidt U., et al. Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1α. J. Biol. Chem. 279 (2004) 44976-44986
16. Nakayama K., and Ronai Z. Siah: new players in the cellular response to hypoxia. Cell Cycle 3 (2004) 1345-1347
17. Ohh M., et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2 (2000) 423-427
18. Jeong J.W., et al. Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111 (2002) 709-720
19. Arnesen T., et al. Interaction between HIF-1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1α. FEBS Lett. 579 (2005) 6428-6432
20. Bilton R., et al. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF. J. Biol. Chem. 280 (2005) 31132-31140
21. Kaelin W.G. Von hippel-lindau disease. Annu. Rev. Pathol. 2 (2007) 145-173
22. Ravi R., et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14 (2000) 34-44
23. Liu Z., et al. cDNA cloning of a novel human ubiquitin carrier protein. An antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. J. Biol. Chem. 267 (1992) 15829-15835
24. Jung C.R., et al. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat. Med. 12 (2006) 809-816
25. Welsh J.B., et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1176-1181
26. Zhong H., et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59 (1999) 5830-5835
27. Baek J.H., et al. OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α. Mol. Cell 17 (2005) 503-512
28. Baek J.H., et al. Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α. J. Biol. Chem. 282 (2007) 23572-23580
29. Su Y.A., et al. Complete sequence analysis of a gene (OS-9) ubiquitously expressed in human tissues and amplified in sarcomas. Mol. Carcinog. 15 (1996) 270-275
30. 1-acetyltransferase-2 (SSAT2) acetylates thialysine and is not involved in polyamine metabolism. Biochem. J. 384 (2004) 139-148
31. Li Z., et al. VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α. EMBO Rep. 6 (2005) 373-378
32. Li Z., et al. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Biochem. Biophys. Res. Commun. 294 (2002) 700-709
33. Li Z., et al. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 277 (2002) 4656-4662
34. Shao R., et al. Increase of SUMO-1 expression in response to hypoxia: direct interaction with HIF-1α in adult mouse brain and heart in vivo. FEBS Lett. 569 (2004) 293-300
35. Bae S.-H., et al. Sumoylation increases HIF-1α stability and its transcriptional activity. Biochem. Biophys. Res. Commun. 324 (2004) 394-400
36. Cheng J., et al. SUMO-specific protease 1 is essential for stabilization of HIF1α during hypoxia. Cell 131 (2007) 584-595
37. Carbia-Nagashima A., et al. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1α during hypoxia. Cell 131 (2007) 309-323
38. 2-independent and HSP90 inhibitor-induced degradation of HIF-11α. Mol. Cell 25 (2007) 207-217
39. 1-acetyltransferase-1 binds to hypoxia-inducible factor-1α (HIF-1α) and RACK1 and promotes ubiquitination and degradation of HIF-1α. J. Biol. Chem. 282 (2007) 33358-33366
40. Liu Y.V., et al. Calcineurin promotes hypoxia-inducible factor 1α expression by dephosphorylating RACK1 and blocking RACK1 dimerization. J. Biol. Chem. 282 (2007) 37064-37073
41. Toker A., and Newton A.C. Cellular signaling: pivoting around PDK-1. Cell 103 (2000) 185-188
42. Mottet D., et al. Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β pathway in HepG2 cells. J. Biol. Chem. 278 (2003) 31277-31285
43. Stiehl D.P., et al. Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512 (2002) 157-162
44. Arsham A.M., et al. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277 (2002) 15162-15170
45. Flugel D., et al. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1α and mediates its destabilization in a VHL-independent manner. Mol. Cell. Biol. 27 (2007) 3253-3265
46. Tang T.T., and Lasky L.A. The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1α by a von Hippel-Lindau protein-independent mechanism. J. Biol. Chem. 278 (2003) 30125-30135
47. Emerling B.M., et al. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 2622-2627
48. Kong X., et al. Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J. Biol. Chem. 282 (2007) 15498-15505
49. Jariel-Encontre I., et al. Ubiquitin-independent degradation of proteins by the proteasome. Biochim. Biophys. Acta (2008). www.sciencedirect.com 10.1016/j.bbcan.2008.1005.1004
50. Laughner E., et al. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21 (2001) 3995-4004
51. Galban S., et al. RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1α. Mol. Cell. Biol. 28 (2008) 93-107
52. Zhou J., and Brune B. Cytokines and hormones in the regulation of hypoxia inducible factor-1α (HIF-1α). Cardiovasc. Hematol. Agents Med. Chem. 4 (2006) 189-197
53. Reiling J.H., and Sabatini D.M. Stress and mTORture signaling. Oncogene 25 (2006) 6373-6383
54. Sonenberg N., and Hinnebusch A.G. New modes of translational control in development, behavior, and disease. Mol. Cell 28 (2007) 721-729
55. Ruvinsky I., et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19 (2005) 2199-2211
56. van den Beucken T., et al. Translational control of gene expression during hypoxia. Cancer Biol. Ther. 5 (2006) 749-755
57. Yu Y.P., et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22 (2004) 2790-2799
58. Koumenis C., and Wouters B.G. "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol. Cancer Res. 4 (2006) 423-436
59. Liu L., et al. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 21 (2006) 521-531
60. Harding H.P., et al. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397 (1999) 271-274
61. Koritzinsky M., et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 25 (2006) 1114-1125
62. Young R.M., et al. Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J. Biol. Chem. 283 (2008) 16309-16319
63. Braunstein S., et al. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol. Cell 28 (2007) 501-512
64. Hui A.S., et al. Calcium signaling stimulates translation of HIF-α during hypoxia. FASEB J. 20 (2006) 466-475
65. Koh M.Y., et al. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1α. Mol. Cancer Ther. 7 (2008) 90-100
66. Lang K.J.D., et al. Hypoxia-inducible factor-1 contains an interna ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell 13 (2002) 1792-1801
67. Zhou J., et al. Functional integrity of nuclear factor κB, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor α-evoked Bcl-2 expression to provoke internal ribosome entry site-dependent translation of hypoxia-inducible factor 1α. Cancer Res. 64 (2004) 9041-9048
68. Schepens B., et al. The polypyrimidine tract-binding protein stimulates HIF-1α IRES-mediated translation during hypoxia. Nucleic Acids Res. 33 (2005) 6884-6894
69. Bert A.G., et al. Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs. RNA 12 (2006) 1074-1083
70. Kozak M. New ways of initiating translation in eukaryotes?. Mol. Cell. Biol. 21 (2001) 1899-1907
71. Schneider R., et al. New ways of initiating translation in eukaryotes. Mol. Cell. Biol. 21 (2001) 8238-8246
72. Seta K.A., et al. The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium 36 (2004) 331-340
73. Liu Q., et al. Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1. Blood 104 (2004) 3993-4001
74. 2+ in hypoxia-induced gene expression in human hepatoma cells (Hep3B). J. Physiol. 517 (1999) 651-657
75. Mottet D., et al. ERK and calcium in activation of HIF-1. Ann. N. Y. Acad. Sci. 973 (2002) 448-453
76. Salnikow K., et al. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol. Cell. Biol. 22 (2002) 1734-1741
77. Werno C., et al. A23187, ionomycin and thapsigargin upregulate mRNA of HIF-1α via endoplasmic reticulum stress rather than a rise in intracellular calcium. J. Cell. Physiol. 215 (2008) 708-714
78. Zhou J., et al. Calpain mediates a von Hippel-Lindau protein-independent destruction of hypoxia-inducible factor-1α. Mol. Biol. Cell 17 (2006) 1549-1558
79. Groulx I., and Lee S. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell. Biol. 22 (2002) 5319-5336
80. Zheng X., et al. Cell-type-specific regulation of degradation of hypoxia-inducible factor 1α: role of subcellular compartmentalization. Mol. Cell. Biol. 26 (2006) 4628-4641
81. Hua Z., et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1 (2006) e116
82. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 73 (2004) 355-382
83. Ciechanover A., et al. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22 (2000) 442-451
84. Brahimi-Horn M.C., and Pouyssegur J. Hypoxia in cancer cell metabolism and pH regulation. Essays Biochem. 43 (2007) 165-178
85. Rankin E.B., and Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15 (2008) 678-685